Inventor
Ved P. SRIVASTAVA
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
A61MDevices for introducing media into, or onto, the body9%
PatentTitleYear
12,540,168Human amylin analog polypeptides and methods of use202612,122,816Long acting peptide tyrosine tyrosine (PYY) analogs and methods of use202412,084,485Long acting glucagon like polypeptide-1 (GLP-1) receptor agonists and methods of use202412,018,059Human amylin analog polypeptides and methods of use202411,840,559Glucagon-receptor selective polypeptides and methods of use thereof202311,739,134Long acting peptide tyrosine tyrosine (PYY) analogs and methods of use202311,214,607Glucagon-receptor selective polypeptides and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to INTARCIA THERAPEUTICS INC (6)· patent assignee history
2022–2026Based in US· patent location history
2023–2026Patents assigned to I2O THERAPEUTICS INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INTARCIA THERAPEUTICS INC | 6 | 2022–2024 |
| I2O THERAPEUTICS INC | 5 | 2023–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2026 |